Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit.
about
Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unitEpidemiology and risk factors for invasive candidiasisPurpurin triggers caspase-independent apoptosis in Candida dubliniensis biofilmsSurveillance of the prevalence, antibiotic susceptibility, and genotypic characterization of invasive candidiasis in a teaching hospital in China between 2006 to 2011.Surveillance of Candida spp bloodstream infections: epidemiological trends and risk factors of death in two Mexican tertiary care hospitalsClinical and microbiological characteristics, and impact of therapeutic strategies on the outcomes of children with candidemia.Species distribution and antifungal susceptibility patterns of Candida isolates from a public tertiary teaching hospital in the Eastern Cape Province, South Africa.A real time PCR assay on blood for diagnosis of invasive candidiasis in immunocompromised patient.The effect of cumulative length of hospital stay on the antifungal resistance of Candida strains isolated from critically ill surgical patients.Comparison of albicans vs. non-albicans candidemia in French intensive care units.Caspofungin at catheter lock concentrations eradicates mature biofilms of Candida lusitaniae and Candida guilliermondii.Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010)Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patientsA risk factor analysis of healthcare-associated fungal infections in an intensive care unit: a retrospective cohort study.Invasive candidiasis in non-hematological patients.Antifungal susceptibilities of bloodstream isolates of Candida species from nine hospitals in Korea: application of new antifungal breakpoints and relationship to antifungal usage.Management of invasive candidiasis in nonneutropenic ICU patients.The rising problem of antimicrobial resistance in the intensive care unit.Inactivation of the antifungal and immunomodulatory properties of human cathelicidin LL-37 by aspartic proteases produced by the pathogenic yeast Candida albicans.Epidemiology of invasive candidiasis in a surgical intensive care unit: an observational study.Impact of prior inappropriate fluconazole dosing on isolation of fluconazole-nonsusceptible Candida species in hospitalized patients with candidemia.Candida parapsilosis and the neonate: epidemiology, virulence and host defense in a unique patient setting.Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project)Candida glabrata among Candida spp. from environmental health practitioners of a Brazilian HospitalSpecies-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates.Fungal infections in intensive care unit: challenges in diagnosis and managementSequence-identification of Candida species isolated from candidemia.Invasive fungal infections in patients with cancer in the Intensive Care Unit.Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007.Invasive fungal infections in the ICU.The risk and clinical outcome of candidemia depending on underlying malignancy.Pharmacokinetic evaluation of fluconazole in critically ill patients.Clinical analysis of deep cutaneous mycoses: a 12-year experience at a single institution.Occurrence, presentation and treatment of candidemia.Molecular fingerprints to identify Candida species.Candida albicans, plasticity and pathogenesis.A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts.Ten-year review of candidemia in a Canadian tertiary care centre: Predominance of non-albicans Candida species.Resistance of Candida spp. to antifungal drugs in the ICU: where are we now?
P2860
Q21194915-C6D71BAC-AAFB-4B3B-9148-2C07A32CD586Q27024911-989ED53F-83BD-41AA-8ABD-9167E3447718Q28537918-0892A504-6181-440E-AF00-7E0A85BA7E72Q30658189-62084C81-8D2A-4E0E-82F3-8C246CF9C011Q33618418-F12F8A00-D66B-4D06-9D8E-40FDFFED2501Q33683476-CF0DBD62-CFF8-41AC-8636-FAC974FF0CEFQ33821355-1CE42635-229B-4800-BE19-4AD0EB5AB807Q33851387-D71EF28D-36B1-495A-907E-AF1C272B0D20Q33887429-392BD20F-60CD-4C9F-9E4E-04D1AD3C58F9Q34026915-318601F6-5F26-4121-98C8-51B5DE9D1BA9Q34058104-A9A31D59-0313-4EA2-9E48-45F209B08FCDQ34100598-6E5C4FE5-E0C3-4E16-A641-2C787D7FC258Q34505582-E8C8BB65-D722-4EDA-A63E-731AEB2A9C7FQ34529026-E8EDF7C5-1D13-43DE-AAC7-B1E8E10D4316Q34539213-B1D66091-DB9B-47CC-B531-800CFA93C847Q35010671-F5AF24C2-70F6-413A-803F-9209D702632DQ35112435-5F2101ED-8A7A-460C-BE77-FD21D7E6B595Q35122093-BB5F24B1-800C-43AD-9A80-0D24B3B581ADQ35595833-0EFF491B-84FC-4958-B02B-14E807F9B77AQ35609334-9AB8F55F-843B-4380-9A2B-B05DB549464CQ35790746-18610D05-BDDC-4883-B398-43C3249E7BE9Q36018860-372BBECC-104C-441C-9E4F-82BE9CF85778Q36401437-FB66558B-6B3C-4B0D-BBD5-2807EF4AA0E4Q36898053-D2AC86D4-94D4-4B8C-AB52-EE16E229EE73Q36921472-DB3547E1-691A-41FA-AB3C-8C7CC9BF918FQ37026730-A6FC8763-E870-44CD-8E35-F1E10F01D3D6Q37058527-03A8C150-A191-46B7-AF9E-A5EE23E0A5ECQ37304217-47E86C33-9384-4DFE-B1ED-CED5E5B8F296Q37373771-1892FA19-5B8C-4A54-B615-41F3ADDB4100Q37374850-B7D22C72-6CA6-40AC-A227-25B8EBCB89EAQ37643057-82081F97-E8EC-4A5E-B42A-64DE788CF49BQ37742252-A2FA16D6-27C4-4283-95DF-A4BA99209324Q37924819-C578580A-05DF-45AD-9DF4-8733016BBAABQ38001158-CC142D62-30D2-4DA9-AE8C-0DAD1D105A70Q38061190-5AB332C6-B986-4A8C-995E-AE584BF80F48Q38120763-1C8D9EF9-E08C-4865-A04C-738EC40FF24BQ38130314-B01FD611-5BEA-4FDD-8985-B6FA70D13CF2Q38150728-C8888DD5-6790-42D6-9ED3-29407F7E5259Q38178257-92EC8914-F7C1-4443-8D19-794BA8BC569CQ38236893-82A071CF-1617-4495-BE6B-25B43E06A7D2
P2860
Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Factors associated with candid ...... ns in the intensive care unit.
@en
Factors associated with candid ...... ns in the intensive care unit.
@nl
type
label
Factors associated with candid ...... ns in the intensive care unit.
@en
Factors associated with candid ...... ns in the intensive care unit.
@nl
prefLabel
Factors associated with candid ...... ns in the intensive care unit.
@en
Factors associated with candid ...... ns in the intensive care unit.
@nl
P2093
P2860
P356
P1476
Factors associated with candid ...... ns in the intensive care unit.
@en
P2093
Adolf W Karchmer
Deborah Lichtenberg
Janet Young
Jennifer K Chow
Robin Ruthazer
Susan Hadley
Varun Chawla
Yehuda Carmeli
Yoav Golan
P2860
P304
P356
10.1086/529435
P407
P577
2008-04-01T00:00:00Z